BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

724 related articles for article (PubMed ID: 32560789)

  • 1. Application of yeast to studying amyloid and prion diseases.
    Chernoff YO; Grizel AV; Rubel AA; Zelinsky AA; Chandramowlishwaran P; Chernova TA
    Adv Genet; 2020; 105():293-380. PubMed ID: 32560789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prion-like disorders: blurring the divide between transmissibility and infectivity.
    Cushman M; Johnson BS; King OD; Gitler AD; Shorter J
    J Cell Sci; 2010 Apr; 123(Pt 8):1191-201. PubMed ID: 20356930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neurodegenerative amyloidoses: the yeast model].
    Vishnevskaia AB; Kushnirov VV; Ter-Avanesian MD
    Mol Biol (Mosk); 2007; 41(2):346-54. PubMed ID: 17514901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Misfolded protein aggregates: mechanisms, structures and potential for disease transmission.
    Moreno-Gonzalez I; Soto C
    Semin Cell Dev Biol; 2011 Jul; 22(5):482-7. PubMed ID: 21571086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Yeast models for amyloid disease.
    Panaretou B; Jones GW
    Essays Biochem; 2014; 56():85-97. PubMed ID: 25131588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How an Infection of Sheep Revealed Prion Mechanisms in Alzheimer's Disease and Other Neurodegenerative Disorders.
    Carlson GA; Prusiner SB
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34064393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mouse models for studying the formation and propagation of prions.
    Watts JC; Prusiner SB
    J Biol Chem; 2014 Jul; 289(29):19841-9. PubMed ID: 24860095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NEURODEGENERATION. Alzheimer's and Parkinson's diseases: The prion concept in relation to assembled Aβ, tau, and α-synuclein.
    Goedert M
    Science; 2015 Aug; 349(6248):1255555. PubMed ID: 26250687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prion-like disorders and Transmissible Spongiform Encephalopathies: An overview of the mechanistic features that are shared by the various disease-related misfolded proteins.
    Eraña H; Venegas V; Moreno J; Castilla J
    Biochem Biophys Res Commun; 2017 Feb; 483(4):1125-1136. PubMed ID: 27590581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. From Seeds to Fibrils and Back: Fragmentation as an Overlooked Step in the Propagation of Prions and Prion-Like Proteins.
    Marrero-Winkens C; Sankaran C; Schätzl HM
    Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32927676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prions: generation and spread versus neurotoxicity.
    Halliday M; Radford H; Mallucci GR
    J Biol Chem; 2014 Jul; 289(29):19862-8. PubMed ID: 24860100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies.
    Ciechanover A; Kwon YT
    Exp Mol Med; 2015 Mar; 47(3):e147. PubMed ID: 25766616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Yeast prions and human prion-like proteins: sequence features and prediction methods.
    Cascarina SM; Ross ED
    Cell Mol Life Sci; 2014 Jun; 71(11):2047-63. PubMed ID: 24390581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure and function of the molecular chaperone Hsp104 from yeast.
    Grimminger-Marquardt V; Lashuel HA
    Biopolymers; 2010 Mar; 93(3):252-76. PubMed ID: 19768774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenic mechanisms of prion protein, amyloid-β and α-synuclein misfolding: the prion concept and neurotoxicity of protein oligomers.
    Ugalde CL; Finkelstein DI; Lawson VA; Hill AF
    J Neurochem; 2016 Oct; 139(2):162-180. PubMed ID: 27529376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prion Diseases: A Unique Transmissible Agent or a Model for Neurodegenerative Diseases?
    Ritchie DL; Barria MA
    Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33540845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mammalian amyloidogenic proteins promote prion nucleation in yeast.
    Chandramowlishwaran P; Sun M; Casey KL; Romanyuk AV; Grizel AV; Sopova JV; Rubel AA; Nussbaum-Krammer C; Vorberg IM; Chernoff YO
    J Biol Chem; 2018 Mar; 293(9):3436-3450. PubMed ID: 29330303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of proteins in neurodegenerative disease].
    Szwed A; Miłowska K
    Postepy Hig Med Dosw (Online); 2012 Apr; 66():187-95. PubMed ID: 22706103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid and prions: some biochemical investigations of cerebral amyloidosis in mice.
    Hope J; Kirby L
    Folia Neuropathol; 2012; 50(1):13-9. PubMed ID: 22505360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Can prion-like propagation occur in neurodegenerative diseases?: in view of transmissible systemic amyloidosis].
    Yoshida K; Higuchi K; Ikeda S
    Brain Nerve; 2012 Jun; 64(6):665-74. PubMed ID: 22647474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.